Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia

Eur J Haematol Suppl. 1987:47:33-42. doi: 10.1111/j.1600-0609.1987.tb00020.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aclarubicin
  • Adolescent
  • Adult
  • Aged
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Middle Aged
  • Naphthacenes / adverse effects
  • Naphthacenes / therapeutic use

Substances

  • Antibiotics, Antineoplastic
  • Naphthacenes
  • Aclarubicin